I

Incyte

Biopharmaceutical company pursuing drug discovery.

GMP Quality Assurance Intern

Regulatory & Quality (Life Sciences)Posted on Nov 12
InternshipMorges, SwitzerlandNo salary listedIn-person

About the Job

Requirements

  • The candidate must be a student pursuing a Master’s degree in Chemistry, Biology, or Pharmacy, or equivalent.
  • The internship is six months and may be part-time to full-time (80–100%).
  • The candidate must demonstrate the ability to write technical documents.
  • The candidate must be fluent in written English and have B2-level spoken English.

Responsibilities

  • Coordinate collection of Contract Manufacturing Organization (CMO) Annual Product Quality Review (APQR) reports and support issuance of Incyte APQR reports.
  • Support vendor management activities, including updating Veeva Organizations and collecting vendor statements.
  • Review and harmonize the classification of Quality Assurance (QA)-related documents in the electronic document management system (eDMS).
  • Support collection of small-molecule vendor batch documentation to prepare Incyte batch disposition.
  • Support management and monitoring of Supplier Change Notifications (SCNs).
  • Support management and monitoring of internal and external Corrective and Preventive Actions (CAPAs).
  • Support management and monitoring of Product Complaints.
  • Support implementation and monitoring of internal Key Parameter Indicators.
  • Perform responsibilities in accordance with company policies, procedures, applicable regulations, and safety requirements.
  • Cooperate with Supply Chain, Commercial Operations, Regulatory Affairs, Small Molecule Clinical Manufacturing QA, and Biologics Manufacturing QA functions.
  • Contribute to a culture of business integrity and ethics.
  • Act in accordance with compliance and legal requirements and company guidelines.

Desired Qualifications

  • French is an asset.
  • The candidate should have good organizational and communication skills, diplomacy, and commitment.

About the Company

Incyte

Biopharmaceutical company pursuing drug discovery.

Incyte develops and sells medicines by discovering and developing new drugs, focusing on diseases in inflammation, autoimmunity, and blood cancers. Its core product, Jakafi (ruxolitinib), is a JAK1/2 inhibitor approved to treat a rare blood cancer and works by blocking JAK enzymes to reduce abnormal blood cell growth. The company also expands its pipeline through research collaborations, partnerships, and acquisitions, such as the 2024 purchase of Escient Pharmaceuticals to strengthen its inflammation and autoimmune portfolio. Unlike some competitors that rely mainly on internal programs, Incyte combines in-house discovery with external collaborations and strategic deals to grow its drug candidates from early research to approved therapies. The goal is to deliver medicines that help patients with serious diseases by building a diverse, clinically validated portfolio of treatments through internal efforts and partnerships.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Wilmington, DE
Founded
1991

Recently Posted Jobs

Explore more opportunities at Incyte

See more jobs